NASDAQ:ADN - Nasdaq - US00788A2042 - Common Stock - Currency: USD
2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 3.28M | 1.54M | 7.84M | 7.07M | 882.70K | |||
Cost Of Goods | 1.49M | 6.96M | 8.58M | 5.41M | 513.80K | |||
Gross Profit | 1.79M | -5.43M | -744.00K | 1.66M | 368.80K | |||
Operating Expenses | 20.16M | 35.52M | 48.13M | 45.77M | 3.44M | |||
Research and Development | 3.23M | 7.57M | 9.80M | 3.54M | 102.50K | |||
Selling, General, and Administrative Expenses | 17.93M | 29.87M | 37.03M | 41.88M | 3.55M | |||
Operating Income | -18.37M | -40.95M | -48.88M | -44.11M | -3.07M | |||
Interest Income/Expense | -807.00K | 205.00K | -39.00K | -94.30K | -31.60K | |||
Other Income/Expense | 66.00K | -476.00K | 9.16M | 22.76M | -15.70K | |||
Non Recurring Items | -4.72M | -9.76M | -36.55M | -3.29M | N/A | |||
Income Before Taxes | -30.07M | -50.98M | -76.31M | -21.45M | -3.12M | |||
Income Tax | -55.00K | -82.00K | -1.97M | -922.50K | 0.00 | |||
Net Income | -40.99M | -71.40M | -74.34M | -20.52M | -3.12M | |||
EBITDA | -16.78M | -37.30M | -44.62M | -42.37M | -3.05M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -15.65 | -37.24 | -43.28 | -13.44 | -2.03 | |||
Non GAAP EPS | N/A | N/A | N/A | -17.40 | N/A | |||
Statistics | ||||||||
Gross Profit Margin | 54.58% | -353.39% | -9.49% | 23.52% | 41.78% | |||
Profit Margin | -1251.34% | -4648.24% | -948.54% | -290.34% | -353.57% | |||
Operating Profit Margin | -560.71% | -2666.02% | -623.64% | -624.01% | -348.22% |
All data in USD